SCHEMBL5373830

SCHEMBL5373830

Cc1ccc(S(=O)(=O)N(c2ccc(C(F)(F)F)cc2)c2ccc3ocnc3c2)cc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.40
RXRB P28702 2/20 0.40
RXRG P48443 1/20 0.40
KCNJ6 P48051 1/20 0.34
KCNJ3 P48549 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TRPM8 Q7Z2W7 2/20 0.34
ACLY P53396 1/20 0.34
KDM1A O60341 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
SERPINE1 P05121 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CSF1R P07333 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5370576 0.92 SMN1; SMN2 (0.35) RXRARXRBRXRGMEN1KMT2A
SCHEMBL5367888 0.90 GAA (0.37) RXRARXRBRXRGKCNJ6KCNJ3
SCHEMBL5368411 0.89 RXRA (0.39) RXRARXRBRXRGMEN1KMT2A
SCHEMBL5371938 0.88 TRPM8 (0.39) TRPM8SERPINE1
SCHEMBL5921908 0.82 TP53 (0.39) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL5377050 0.82 SMN1; SMN2 (0.41) MEN1KMT2AALDH1A1GAANPC1
SCHEMBL5391241 0.81 ALDH1A1 (0.35) RXRARXRBRXRGMEN1KMT2A
SCHEMBL5382107 0.80 SMN1; SMN2 (0.35) MEN1KMT2ATRPM8ALDH1A1NPC1
SCHEMBL5376611 0.80 SMN1; SMN2 (0.34) MEN1KMT2AALDH1A1GAANPC1
SCHEMBL5368704 0.78 TRPM8 (0.41) TRPM8ALDH1A1SERPINE1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725524-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS Pfizer Products Incorporated (US) 2006-11-29 EP claimed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US claimed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US claimed
WO-2005092845-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER PRODUCTS INC. (US) 2005-10-06 WO claimed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
EP-1725524-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS Pfizer Products Incorporated (US) 2006-11-29 EP disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed
WO-2005092845-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER PRODUCTS INC. (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD RXRA 44/4885RXRB 66/4885RXRG 52/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD RXRA 69/4885RXRB 86/4885RXRG 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.